Pharmabiz11h
Daiichi Sankyo appoints Hiroyuki Okuzawa as chief executive officer
Daiichi Sankyo appoints Hiroyuki Okuzawa as chief executive officer: Tokyo Saturday, February 1, 2025, 12:30 Hrs [IST] ...
Pharmabiz5h
Onco-Innovations’ licensed technology demonstrates promise to enhance chemotherapy effectiveness by overcoming cancer cell resistance
Onco-Innovations’ licensed technology demonstrates promise to enhance chemotherapy effectiveness by overcoming cancer cell resistance: Vancouver, BC Saturday, February 1, 2025, ...
Pharmabiz7h
Celltrion’s Avtozma, a biosimilar to Actemra receives US FDA approval to treat RA, GCA, pJIA, sJIA and Covid-19
Jersey City, New Jersey Saturday, February 1, 2025, 16:00 Hrs [IST] ...
Pharmabiz7h
Budget 2025 proposes to transform cancer care, medical education, and global healthcare leadership: Experts
Budget 2025 proposes to transform cancer care, medical education, and global healthcare leadership: Experts: Our Bureau, Mumbai Saturday, February 1, 2025, 15:40 Hrs [IST] The Uni ...
Pharmabiz6h
Union budget 2025 defeats the objective of Make in India programme: KDPMA
Union budget 2025 defeats the objective of Make in India programme: KDPMA: Nandita Vijayasimha, Bengaluru Saturday, February 1, 2025, 17:20 Hrs [IST] The Karnataka Drugs and Pharm ...
Pharmabiz6h
Telix Pharma completes acquisition of next-generation therapeutic assets & innovative biologics technology platform of ImaginAb
Telix Pharma completes acquisition of next-generation therapeutic assets & innovative biologics technology platform of ImaginAb: Melbourne, Australia Saturday, February 1, 2025, 1 ...
Pharmabiz6h
Health budget witnesses 9.7% growth, experts laud decisions related to healthcare
Health budget witnesses 9.7% growth, experts laud decisions related to healthcare: Our Bureau, New Delhi Saturday, February 1, 2025, 17:05 Hrs [IST] The Union Budget 2025 has prop ...
Pharmabiz6h
Indian pharma gives thumbs up to Budget’s Manufacturing Mission & classification of MSME criteria
Indian pharma gives thumbs up to Budget’s Manufacturing Mission & classification of MSME criteria: Our Bureau, Bengaluru Saturday, February 1, 2025, 16:45 Hrs [IST] India pharma ...
Pharmabiz7h
Medical devices industry disappointed over Union Budget 2025
With the Union Budget 2025 skipped mentioning medical devices sector directly or addressing the industry demands including custom duty structure, the industry associations said that they are ...
Pharmabiz9h
Vertex Pharmaceuticals’ suzetrigine gets US FDA approval for treatment of adults with moderate-to-severe acute pain
Vertex Pharmaceuticals’ suzetrigine gets US FDA approval for treatment of adults with moderate-to-severe acute pain: Boston Saturday, February 1, 2025, 14:00 Hrs [IST] Vertex Ph ...
Pharmabiz10h
Enveric Biosciences receives notice of allowance from USPTO for its drug candidate EB-003 to treat mental health disorders
Enveric Biosciences receives notice of allowance from USPTO for its drug candidate EB-003 to treat mental health disorders: Cambridge, Massachusetts Saturday, February 1, 2025, 13 ...
Pharmabiz11h
China NMPA approves Sanofi’s Sarclisa for patients with newly diagnosed multiple myeloma ineligible for transplant
China NMPA approves Sanofi’s Sarclisa for patients with newly diagnosed multiple myeloma ineligible for transplant: Paris Saturday, February 1, 2025, 12:00 Hrs [IST] The Nationa ...